BioLASCO Taiwan Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	263.81	262.66	292.5	264.72	235.91	227.58
Revenue Growth (YoY)	-13.41%	-10.20%	10.49%	12.21%	3.66%	-23.86%
Cost of Revenue	157.75	157.89	177.74	160.37	131.43	122.47
Gross Profit	106.05	104.78	114.76	104.35	104.49	105.11
Selling, General & Admin	56.61	56.66	59.06	53.54	55.22	51.18
Operating Expenses	56.6	56.73	59.02	53.59	55.22	51.21
Operating Income	49.46	48.04	55.74	50.76	49.27	53.89
Interest Expense	-2.03	-2.03	-1.76	-1.3	-1.09	-0.88
Interest & Investment Income	1.59	1.61	2.41	1.83	0.73	0.47
Earnings From Equity Investments	0.26	0.81	1.72	8.72	4.68	2.72
Currency Exchange Gain (Loss)	-	-	0.18	0.31	-0.52	0.2
Other Non Operating Income (Expenses)	1.59	1.13	0.28	1.66	0.05	0.04
EBT Excluding Unusual Items	50.86	49.56	58.56	61.99	53.14	56.44
Other Unusual Items	-	-	-3.64	-	-	-
Pretax Income	50.86	49.56	54.92	61.99	53.14	56.44
Income Tax Expense	7.47	7.14	10.89	12.25	10.83	11.29
Earnings From Continuing Operations	43.39	42.43	44.03	49.74	42.31	45.15
Net Income	43.39	42.43	44.03	49.74	42.31	45.15
Net Income to Common	43.39	42.43	44.03	49.74	42.31	45.15
Net Income Growth	-3.39%	-3.63%	-11.49%	17.57%	-6.29%	-28.10%
Shares Outstanding (Basic)	-	26	26	26	26	26
Shares Outstanding (Diluted)	-	26	26	26	26	26
Shares Change (YoY)	-	0.24%	-0.02%	-0.00%	-0.02%	-0.03%
EPS (Basic)	-	1.65	1.72	1.94	1.65	1.76
EPS (Diluted)	-	1.65	1.72	1.94	1.65	1.76
EPS Growth	-	-4.02%	-11.39%	17.58%	-6.25%	-28.16%
Free Cash Flow	31.75	27.06	1.04	27.83	40.88	66.62
Free Cash Flow Per Share	-	1.05	0.04	1.08	1.59	2.60
Dividend Per Share	-	-	1.500	1.650	1.500	1.600
Dividend Growth	-	-	-9.09%	10.00%	-6.25%	-20.00%
Gross Margin	40.20%	39.89%	39.23%	39.42%	44.29%	46.18%
Operating Margin	18.75%	18.29%	19.06%	19.18%	20.88%	23.68%
Profit Margin	16.45%	16.15%	15.05%	18.79%	17.94%	19.84%
Free Cash Flow Margin	12.04%	10.30%	0.35%	10.51%	17.33%	29.27%
EBITDA	61.53	59.58	64.45	58.96	56.91	62.07
EBITDA Margin	23.32%	22.68%	22.04%	22.27%	24.12%	27.27%
D&A For EBITDA	12.07	11.53	8.71	8.2	7.64	8.18
EBIT	49.46	48.04	55.74	50.76	49.27	53.89
EBIT Margin	18.75%	18.29%	19.06%	19.18%	20.88%	23.68%
Effective Tax Rate	14.69%	14.40%	19.83%	19.76%	20.38%	20.00%